カテゴリ： GlobalData, アメリカ, 企業調査

Merck & Co Inc (MRK)：医療機器：M&Aディール及び事業提携情報

◆英語タイトル：Merck & Co Inc (MRK) - Medical Equipment - Deals and Alliances Profile
◆商品コード：DATA904C7377
◆発行会社（調査会社）：GlobalData
◆発行日：2018年10月
◆ページ数：139
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：アメリカ
◆産業分野：医療機器
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD250 ⇒換算￥37,000見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD500 ⇒換算￥74,000見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD750 ⇒換算￥111,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※GlobalData社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Summary
Merck & Co Inc (Merck) is a biopharmaceutical company that focuses on the discovery, development, manufacture and commercialization of prescription medicines, biologic therapies, vaccines and animal health products. It offers prescription products for treating cardiovascular, cancer, immune disorders, infectious, respiratory and women’s diseases, and diabetes. The company provides animal health products including vaccines, poultry products, livestock products and aquaculture products. Merck sells medicines to drug wholesalers, retailers, hospitals, government agencies and managed health care providers; and animal health products to veterinarians, distributors and animal producers. Outside the US, the company operates through subsidiaries. It operates in the Americas, Europe, the Middle East, Africa, Asia Pacific, and Latin America. Merck is known as MSD outside the US and Canada and is headquartered in Kenilworth, New Jersey, the US.

Merck & Co Inc (MRK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 6
List of Figures 7
Merck & Co Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Merck & Co Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Merck & Co Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Merck & Co Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 11
Merck & Co Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Merck & Co Inc, Medical Equipment, Deal Details 18
Venture Financing 18
Grail Raises USD914 Million in First Tranche of Series B Financing 18
Livongo Health Raises USD44.5 Million in Series C Financing Round 21
WellDoc Raises USD22 Million in First Tranche of Series B Financing 23
CareSync Raises USD18 Million in Series B Financing 24
Navigating Cancer Raises USD10 Million in Financing Round 25
RaNA Therapeutics Raises USD55 Million in series B Financing 26
MedCPU Raises USD8 Million in Financing Round 27
ClearData Networks Raises USD25 Million in Series C Financing 28
Liaison Technologies Raises Funds through Venture Financing 29
Daktari Diagnostics Raises USD15.5 Million in Series D Financing 30
Aventura Raises USD14 Million in Series C Financing 31
WiserTogether Raises USD9 Million in Series B Venture Financing 32
Healthsense Raises USD10 Million in Venture Financing 33
ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 34
ImaginAb Raises USD21 Million in Series B Venture Financing 35
MedCPU Raises USD9.3 Million in Series B Financing 36
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 37
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 38
WellDoc Raises US$15.7 Million In Venture Financing 39
ClearData Networks Raises US$14 Million In Series B Financing 40
GenomeDx Biosciences Raises Funds Through Series B Financing 41
PatientSafe Solutions Raises US$27 Million In Series C Venture Financing 42
Aviir Raises US$20 Million In Venture Financing 44
eHealth Technologies Raises US$6 Million In Series D Financing 46
Remedy Informatics Raises US$6 Million In Venture Financing 47
Healthsense Raises US$7 Million In Series D Financing 48
Liaison Technologies Raises US$30 Million In Venture Financing 49
Physicians Interactive Holdings Secures US$8.5 Million In Venture Financing 50
Private Equity 51
Merck Global Health Acquires Physicians Interactive From Perseus 51
Partnerships 52
Merck Enters into Licensing Agreement with ImaginAb 52
Cerveau Technologies Enters into Licensing Agreement with Merck 53
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 54
Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 55
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 56
CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test 57
OpGen Enters into Research Agreement with Merck 58
Takeda Pharma Enters into Agreement with Koneksa Health 59
Merck Enters into Co-Development Agreement with Amoy Diagnostics 60
Enigma Biomedical Enters into Research Agreement with Biogen and Merck 61
Merck to Enter into Co-Development Agreement with Biocartis 62
Daktari Diagnostics Enters into Agreement with Merck 63
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 64
Dako Enters into Agreement with Merck for Companion Diagnostic Test 65
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 66
Physicians Interactive Enters Into Agreement With Greenway For eCoupon 67
Merck Enters Into Co-Development Agreement With Geisinger Health System 68
Perrigo Enters into Licensing Agreement with Merck 69
Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 70
Equity Offering 71
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 71
VirtualScopics Completes First Tranche Of Private Placement Of Shares For US$3 Million 73
Debt Offering 74
Merck Plans to Raise Funds through Public Offering of Debt Securities 74
Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 75
Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 76
Acquisition 77
OpGen Acquires AdvanDx 77
Physicians Interactive Acquires Tomorrow Networks 78
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 79
Physicians Interactive Acquires InfoMedics, Provider Of Patient Feedback Solutions 81
Merck & Co Inc – Key Competitors 82
Merck & Co Inc – Key Employees 83
Merck & Co Inc – Locations And Subsidiaries 85
Head Office 85
Other Locations & Subsidiaries 85
Joint Venture 107
Recent Developments 109
Strategy And Business Planning 109
Jul 17, 2017: Governor Abbott Announces Merck IT Hub In Austin 109
Financial Announcements 110
Jul 27, 2018: Merck Announces Second-Quarter 2018 Financial Results 110
May 01, 2018: Merck Announces First-Quarter 2018 Financial Results 114
Oct 27, 2017: Merck Announces Third-Quarter 2017 Financial Results 117
Jul 28, 2017: Merck Announces Second-Quarter 2017 Financial Results 119
May 02, 2017: Merck Announces First-Quarter 2017 Financial Results 122
Feb 02, 2017: Merck Announces Fourth-Quarter and Full-Year 2016 Financial Results 124
Corporate Communications 126
Mar 20, 2018: Merck Names Jennifer Zachary As General Counsel 126
Jan 24, 2018: Merck Names Inge Thulin To Board Of Directors 127
Apr 10, 2017: Dr. John H. Noseworthy Nominated to Stand for Election to Merck Board of Directors 128
Apr 06, 2017: Merck Receives 2017 ENERGY STAR Sustained Excellence Award from U. S. Environmental Protection Agency 129
Government and Public Interest 130
Jul 17, 2018: Merck Announces Future Insight Prize of up to € 1 Million for Groundbreaking Scientific Work 130
Mar 31, 2017: City Of Austin Announces Merck Economic Development Proposal 131
Product News 132
Aug 14, 2018: Geisinger and Merck unveil new applications developed to help improve patient communication and care delivery 132
Other Significant Developments 134
Oct 08, 2018: Merck’s novel Chemiflex raw materials program solves regulatory compliance challenges in small molecule drug manufacturing 134
Sep 20, 2018: Merck publishes Corporate Responsibility Report 135
Aug 15, 2018: Geisinger, Merck partner to launch EHR-Integrated FHIR Apps 136
Jul 19, 2018: Merck Reinforces Commitment to Responsible Pricing 138
Appendix 139
Methodology 139
About GlobalData 139
Contact Us 139
Disclaimer 139

List of Tables
Merck & Co Inc, Medical Equipment, Key Facts, 2017 2
Merck & Co Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Merck & Co Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Merck & Co Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 9
Merck & Co Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Merck & Co Inc, Deals By Market, 2012 to YTD 2018 11
Merck & Co Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 12
Grail Raises USD914 Million in First Tranche of Series B Financing 18
Livongo Health Raises USD44.5 Million in Series C Financing Round 21
WellDoc Raises USD22 Million in First Tranche of Series B Financing 23
CareSync Raises USD18 Million in Series B Financing 24
Navigating Cancer Raises USD10 Million in Financing Round 25
RaNA Therapeutics Raises USD55 Million in series B Financing 26
MedCPU Raises USD8 Million in Financing Round 27
ClearData Networks Raises USD25 Million in Series C Financing 28
Liaison Technologies Raises Funds through Venture Financing 29
Daktari Diagnostics Raises USD15.5 Million in Series D Financing 30
Aventura Raises USD14 Million in Series C Financing 31
WiserTogether Raises USD9 Million in Series B Venture Financing 32
Healthsense Raises USD10 Million in Venture Financing 33
ElectroCore Raises Additional USD10 Million in Second Tranche of Venture Financing 34
ImaginAb Raises USD21 Million in Series B Venture Financing 35
MedCPU Raises USD9.3 Million in Series B Financing 36
AdvanDx Raises US$12 Million In Series B-1 Venture Financing 37
HTG Molecular Diagnostics Raises Funds Through Extended Series E Financing 38
WellDoc Raises US$15.7 Million In Venture Financing 39
ClearData Networks Raises US$14 Million In Series B Financing 40
GenomeDx Biosciences Raises Funds Through Series B Financing 41
PatientSafe Solutions Raises US$27 Million In Series C Venture Financing 42
Aviir Raises US$20 Million In Venture Financing 44
eHealth Technologies Raises US$6 Million In Series D Financing 46
Remedy Informatics Raises US$6 Million In Venture Financing 47
Healthsense Raises US$7 Million In Series D Financing 48
Liaison Technologies Raises US$30 Million In Venture Financing 49
Physicians Interactive Holdings Secures US$8.5 Million In Venture Financing 50
Merck Global Health Acquires Physicians Interactive From Perseus 51
Merck Enters into Licensing Agreement with ImaginAb 52
Cerveau Technologies Enters into Licensing Agreement with Merck 53
Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 54
Merck Enters Into Licensing Agreement With Vaxxas For Nanopatch Technology 55
HTG Molecular Diagnostics Enters Into Licensing Agreement With Merck For Breast Cancer Marker Patent Portfolio 56
CogState Enters Into Licensing Agreement With Merck Canada For Cognition Test 57
OpGen Enters into Research Agreement with Merck 58
Takeda Pharma Enters into Agreement with Koneksa Health 59
Merck Enters into Co-Development Agreement with Amoy Diagnostics 60
Enigma Biomedical Enters into Research Agreement with Biogen and Merck 61
Merck to Enter into Co-Development Agreement with Biocartis 62
Daktari Diagnostics Enters into Agreement with Merck 63
Cepheid Enters into Co-Development Agreement with AstraZeneca, Cubist Pharma and GSK 64
Dako Enters into Agreement with Merck for Companion Diagnostic Test 65
Cardiome Pharma Enters Into Co-Marketing Agreement With Merck For Brinavess 66
Physicians Interactive Enters Into Agreement With Greenway For eCoupon 67
Merck Enters Into Co-Development Agreement With Geisinger Health System 68
Perrigo Enters into Licensing Agreement with Merck 69
Merck Enters Into Licensing Agreement With GE Healthcare For Flutemetamol 70
OpGen Raises USD10.4 Million in Private Placement of Shares and Warrants 71
VirtualScopics Completes First Tranche Of Private Placement Of Shares For US$3 Million 73
Merck Plans to Raise Funds through Public Offering of Debt Securities 74
Merck Raises USD544 Million in Public Offering of 1.375% Notes Due 2036 75
Merck Raises USD544 Million in Public Offering of 0.5% Notes Due 2024 76
OpGen Acquires AdvanDx 77
Physicians Interactive Acquires Tomorrow Networks 78
Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 79
Physicians Interactive Acquires InfoMedics, Provider Of Patient Feedback Solutions 81
Merck & Co Inc, Key Competitors 82
Merck & Co Inc, Key Employees 83
Merck & Co Inc, Subsidiaries 85
Merck & Co Inc, Joint Venture 107

List of Figures
Merck & Co Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Merck & Co Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Merck & Co Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Merck & Co Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Merck & Co Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 8
Merck & Co Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 9
Merck & Co Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 10
Merck & Co Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 11

★海外企業調査レポート[Merck & Co Inc (MRK)：医療機器：M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Compagnie Ivoirienne d’Electricite (CIEC)：企業の財務・戦略的SWOT分析
    Summary Compagnie Ivoirienne d'Electricite (CIE), a subsidiary of Eranove, is a power company that provides power generation, transmission, and distribution services. The company offers exporting, importing and marketing of electricity. It provides operation and management of hydroelectric and therm …
  • Top Frontier Investment Holdings Inc：企業の戦略・SWOT・財務分析
    Top Frontier Investment Holdings Inc - Strategy, SWOT and Corporate Finance Report Summary Top Frontier Investment Holdings Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • AusTex Oil Ltd：企業の戦略的SWOT分析
    AusTex Oil Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • XTL Biopharmaceuticals Ltd (XTLB)：企業の財務・戦略的SWOT分析
    Summary XTL Biopharmaceuticals Ltd (XTL) is a drug development company that focuses on the acquisition and development of late-stage pharmaceutical product candidates for the treatment of unmet clinical needs. The company’s pipeline products include hCDR1 peptide and recombinant human erythropoietin …
  • Bank Of Ningbo Co. Ltd.：企業の戦略・SWOT・財務分析
    Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report Summary Bank Of Ningbo Co. Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Hyundai Corporation：企業の戦略・SWOT・財務情報
    Hyundai Corporation - Strategy, SWOT and Corporate Finance Report Summary Hyundai Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Oilex Ltd (OEX)：石油・ガス：M&Aディール及び事業提携情報
    Summary Oilex Ltd (Oilex) is an oil and gas company that acquires, explores and develops petroleum resources. The company’s projects in Australia include STP-EPA-0106, STP-EPA-0131, and STP-EPA-0107. Its STP-EPA-0106 project is located in onshore north-western Australia. Oilex’s Indian projects are …
  • Redcape Hotel Group：企業の戦略・SWOT・財務情報
    Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report Summary Redcape Hotel Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Eaton Corporation Plc (ETN)：企業の財務・戦略的SWOT分析
    Eaton Corporation Plc (ETN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Datang International Power Generation Co Ltd (991)-エネルギー分野：企業M&A・提携分析
    Summary Datang International Power Generation Company Limited (Datang Power), a subsidiary of China Datang Corporation, is an independent power generation company. It develops power plants; produces and distributes electricity; and sells heat. The company generates electricity from coal-fired genera …
  • Votorantim Energia Ltda：企業の戦略的SWOT分析
    Votorantim Energia Ltda - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Actuated Medical Inc：企業の製品パイプライン分析2018
    Summary Actuated Medical Inc (Actuated Medical) is a medical device company that develops minimally invasive instruments. The company provides products such as controlled tissue penetration systems, occlusion clearing systems and MRI compatible systems. Its controlled tissue penetration systems use …
  • Enbridge Energy Partners LP (EEP)：企業の財務・戦略的SWOT分析
    Enbridge Energy Partners LP (EEP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Kuoni Travel Holding Ltd.：企業のM&A・事業提携・投資動向
    Kuoni Travel Holding Ltd. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Kuoni Travel Holding Ltd. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • Entergy Corporation：企業の戦略・SWOT・財務情報
    Entergy Corporation - Strategy, SWOT and Corporate Finance Report Summary Entergy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Altana Ag：企業の戦略・SWOT・財務分析
    Altana Ag - Strategy, SWOT and Corporate Finance Report Summary Altana Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • MannKind Corp (MNKD)：医療機器：M&Aディール及び事業提携情報
    Summary MannKind Corp (MannKind) is a biopharmaceutical company that develops and commercializes inhaled therapeutic products for patients suffering from diabetes and pulmonary arterial hypertension. Its flagship product, Afrezza is a US FDA approved rapid-action inhaled insulin used to control high …
  • Amathus Public Ltd：企業の戦略・SWOT・財務情報
    Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report Summary Amathus Public Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pioneer Natural Resources Co (PXD)：企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • MSM Malaysia Holdings Berhad (MSM)：企業の財務・戦略的SWOT分析
    MSM Malaysia Holdings Berhad (MSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆